Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B U Sevin

Showing results (71-80 of 136) with videos related to

Pageof 14
Sort By:
Gynecologic Oncology|September 1, 1991
Comparative evaluation of single and combination chemotherapy in uterine cancer cell linesH N Nguyen, B U Sevin, H E Averette, et al.
Gynecologic Oncology|May 1, 1992
The use of ATP bioluminescence assays in selecting a drug screen panel for chemosensitivity testing of uterine cancer cell linesH N Nguyen, B U Sevin, H E Averette, et al.
American Journal of Clinical Oncology|April 16, 1998
Amonafide in patients with leiomyosarcoma of the uterus: a phase II Gynecologic Oncology Group studyR Asbury, J A Blessing, R Buller, et al.
Gynecologic Oncology|October 1, 1981
Lymphatic metastasis in apparently early carcinoma of the ovaryS A Metz, B U Sevin, H E Averete, et al.
Journal of Surgical Oncology|April 1, 1993
Preliminary experience with a modified Tenckhoff catheter for intraperitoneal chemotherapyH N Nguyen, H E Averette, L Wyble, et al.
Gynecologic Oncology|May 1, 1986
In vivo chemosensitivity testing in patients with gynecologic malignancies and nude mouse xenografts by monitoring cell kinetic parameters and DNA distribution patterns: a preliminary reportB U Sevin, A Pollack, H E Averette, et al.
Gynecologic Oncology|August 1, 1990
Comparative chemosensitivity profiles in four human ovarian carcinoma cell lines measuring ATP bioluminescenceE Petru, B U Sevin, J Perras, et al.
Gynakologisch-Geburtshilfliche Rundschau|January 1, 1993
[Testing chemosensitivity of cancer cell lines and gynecologic tumors with the ATP assay]M Untch, B U Sevin, A Untch, et al.
Cancer Investigation|January 1, 1993
In vitro evaluation of the novel chemotherapeutic agents U-73,975, U-77,779, and U-80,244 in gynecologic cancer cell linesR D Hightower, B U Sevin, J Perras, et al.
Gynecologic Oncology|September 1, 1988
HIV status and positive Papanicolaou screening: identification of a high-risk populationD Provencher, B Valme, H E Averette, et al.
Pageof 14

Showing results (71-80 of 136) with videos related to

Sort By:
Pageof 14
Gynecologic Oncology|September 1, 1991
Comparative evaluation of single and combination chemotherapy in uterine cancer cell linesH N Nguyen, B U Sevin, H E Averette, et al.
Gynecologic Oncology|May 1, 1992
The use of ATP bioluminescence assays in selecting a drug screen panel for chemosensitivity testing of uterine cancer cell linesH N Nguyen, B U Sevin, H E Averette, et al.
American Journal of Clinical Oncology|April 16, 1998
Amonafide in patients with leiomyosarcoma of the uterus: a phase II Gynecologic Oncology Group studyR Asbury, J A Blessing, R Buller, et al.
Gynecologic Oncology|October 1, 1981
Lymphatic metastasis in apparently early carcinoma of the ovaryS A Metz, B U Sevin, H E Averete, et al.
Journal of Surgical Oncology|April 1, 1993
Preliminary experience with a modified Tenckhoff catheter for intraperitoneal chemotherapyH N Nguyen, H E Averette, L Wyble, et al.
Gynecologic Oncology|May 1, 1986
In vivo chemosensitivity testing in patients with gynecologic malignancies and nude mouse xenografts by monitoring cell kinetic parameters and DNA distribution patterns: a preliminary reportB U Sevin, A Pollack, H E Averette, et al.
Gynecologic Oncology|August 1, 1990
Comparative chemosensitivity profiles in four human ovarian carcinoma cell lines measuring ATP bioluminescenceE Petru, B U Sevin, J Perras, et al.
Gynakologisch-Geburtshilfliche Rundschau|January 1, 1993
[Testing chemosensitivity of cancer cell lines and gynecologic tumors with the ATP assay]M Untch, B U Sevin, A Untch, et al.
Cancer Investigation|January 1, 1993
In vitro evaluation of the novel chemotherapeutic agents U-73,975, U-77,779, and U-80,244 in gynecologic cancer cell linesR D Hightower, B U Sevin, J Perras, et al.
Gynecologic Oncology|September 1, 1988
HIV status and positive Papanicolaou screening: identification of a high-risk populationD Provencher, B Valme, H E Averette, et al.
Pageof 14